Skip to content

Clinical trials

Phase 2 Scleroderma, Systemic trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Scleroderma, Systemic Phase: Phase 2 Country / region: Canada Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20092
20101
20131
20151
20161
20171
20191
20221
20242
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting2
Terminated2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's3
United Therapeutics2
Bayer1
Boehringer Ingelheim1
Centre hospitalier de l'Université de Montréal (CHUM)1
EMD Serono Research & Development Institute, Inc.1
Genentech, Inc.1
GlaxoSmithKline1
Ottawa Hospital Research Institute1
Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Scleroderma, Systemic13
Scleroderma, Diffuse7
Lung Diseases, Interstitial3
Skin Diseases3
Connective Tissue Diseases2
Peripheral Vascular Diseases1
Raynaud Disease1
Scleroderma, Limited1
Ulcer1
Vascular Diseases1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.